Popular Articles
Stretch Mark

Health Debate Finds New Leaders; Congress Misses Some Old Ones
The cast of characters spearheading the health care debate in Congress doesn"t contain all of the usual suspects.
generic viagra online
AMA Welcomes NHHRC Final Report, Australia
The AMA has congratulated the National Health and Hospitals Reform Commission on its final report launched in Canberra by Prime Minister Kevin Rudd.
News of the day
Also In Global Health News: Uganda ARVs; Malaria In Yemen; Seasonal Hunger; Zimbabwe Maternal Deaths; Nigeria Polio Campaign
Lack Of Funds Prevents HIV-Positive People In Uganda From Receiving Antiretroviral Treatment
Endocrinology

Review Of Brazil's HIV/AIDS Treatment Programs Shows Importance Of Generic Drugs, Researchers Say

"Brazil has been successful in its nearly 20-year effort to treat people living with" HIV/AIDS, and generic medicines have been "a large part of the solution," according to a recent Health Affairs review, UPI reports (UPI, 7/14). The review examines Brazil"s passing of "a law in the 1990s that guaranteed citizens free and universal access to drugs for HIV and AIDS treatment" as well as the country"s production of generic HIV/AIDS medicines in public factories, AHN reports. "The [Brazilian] government also prompted drug companies to lower their prices by threatening to make generic versions of [patented] HIV and AIDS drugs in the public factories," writes AHN (Goodhue, 7/14). "Brazil has proved it is possible to treat people with AIDS in developing countries," said lead author Amy Nunn, an assistant professor at Brown University, in a written statement. "[T]he country saved more than $1 billion as a result of bargaining with multinational pharmaceutical companies, resulting in significant changes in global AIDS policy," according to a Brown University/EurekAlert! release (7/14). "Although Brazil"s exact model might not be replicated elsewhere, it provides evidence that AIDS treatment is possible in a developing country," the authors write, adding, "Other countries, particularly middle-income countries, have learned much from Brazil"s experience as they now negotiate deep discounts with pharmaceutical companies, benefit from tiered pricing structures, issue compulsory licenses, rely increasingly on generics, work with blossoming civil-society movements, implement new health infrastructure, and provide millions of people with AIDS treatment" (Nunn et. al, Health Affairs, 7/09). This information was reprinted from globalhealth.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives and sign up for email delivery at globalhealth.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):